Skip to main content
. 2022 Jan 19;40(8):1162–1169. doi: 10.1016/j.vaccine.2022.01.007

Fig. 3.

Fig. 3

Reactivity of convalescent human sera against the RBDf protein, measured by ELISA. SH 34–39, 41 and 45: convalescents human sera; N1, 3, 7 and 9: negative human sera.